HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ruibai Wang Selected Research

CAP protocol 2

11/2019Synergistic activities of clofazimine with moxifloxacin or capreomycin against Mycobacterium tuberculosis in China.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ruibai Wang Research Topics

Disease

3Infections
03/2022 - 10/2004
2Tuberculosis (Tuberculoses)
11/2019 - 01/2019
1Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
11/2019
1Cholera
01/2018

Drug/Important Bio-Agent (IBA)

2Anti-Bacterial Agents (Antibiotics)IBA
01/2020 - 01/2018
1Clofazimine (Lamprene)FDA Link
11/2019
1Pharmaceutical PreparationsIBA
11/2019
1Biomarkers (Surrogate Marker)IBA
01/2019
1Azithromycin (Zithromax)FDA LinkGeneric
01/2018
1flaB flagellinIBA
10/2004

Therapy/Procedure

1Therapeutics
03/2022
1CAP protocol 2
11/2019